Regulation of the expression of GABAA receptor subunits by an antiepileptic drug QYS

Neuroscience Letters

Volumn 392, Issue 1-2, 2006, Pages 145-149

  Li, Xianchun ^a   Yang, Qingxiong ^b   Hu, Yinghe ^a  

^a B326 Science Building   (China)

^b Yunnan Yunyao Laboratory Co Ltd   (China)

Author keywords

Central nervous system (CNS); GABAA receptor; Gene expression; Qingyangshenylycosides

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; ANTICONVULSIVE AGENT; QINGYANGSHENYLYCOSIDE; RECEPTOR SUBUNIT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; BRAIN REGION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; GABAERGIC SYSTEM; GENE EXPRESSION REGULATION; HIPPOCAMPUS; INFERIOR COLLICULUS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; UPREGULATION;

ANIMALS; ANTICONVULSANTS; BRAIN; DRUGS, CHINESE HERBAL; GENE EXPRESSION REGULATION; MICE; MICE, INBRED DBA; PROTEIN SUBUNITS; RECEPTORS, GABA-A; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 28744440409     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2005.09.011     Document Type: Article

References (46)

1. G. Avanzini, and S. Franceschetti Cellular biology of epileptogenesis Lancet Neurol. 2 1 2003 33 42
2. S. Baulac, G. Huberfeld, I. Gourfinkel-An, G. Mitropoulou, A. Beranger, J.F. Prud'homme, M. Baulac, A. Brice, R. Bruzzone, and E. LeGuern First genetic evidence of GABA(A) receptor dysfunction in epilepsy: a mutation in the gamma2-subunit gene Nat. Genet. 28 1 2001 46 48
3. A. Billinton, V.H. Baird, M. Thom, J.S. Duncan, N. Upton, and N.G. Bowery GABA(B(1)) mRNA expression in hippocampal sclerosis associated with human temporal lobe epilepsy Brain Res. Mol. Brain Res. 86 1-2 2001 84 89
4. R.B. Carter, P.L. Wood, S. Wieland, J.E. Hawkinson, D. Belelli, J.J. Lambert, H.S. White, H.H. Wolf, S. Mirsadeghi, S.H. Tahir, M.B. Bolger, N.C. Lan, and K.W. Gee Characterization of the anticonvulsant properties of ganaxolone (CCD 1042; 3alpha-hydroxy-3beta-methyl-5alpha-pregnan-20-one), a selective, high-affinity, steroid modulator of the gamma-aminobutyric acid(A) receptor J. Pharmacol. Exp. Ther. 280 3 1997 1284 1295
5. P. Cossette, L. Liu, K. Brisebois, H. Dong, A. Lortie, M. Vanasse, J.M. Saint-Hilaire, L. Carmant, A. Verner, W.Y. Lu, Y.T. Wang, and G.A. Rouleau Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy Nat. Genet. 31 2 2002 184 189
6. B.R. Danielsson, K. Lansdell, L. Patmore, and T. Tomson Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents Epilepsy Res. 63 1 2005 17 25
7. T. Degim, R. Dundaroz, A. Sizlan, M. Yasar, M. Denli, and E. Gokcay The use of the corpus cavernosum for the administration of phenobarbital: an experimental study in dogs Int. J. Pharm. 246 1-2 2002 105 109
8. C.L. Faingold, and A. Riaz Ethanol withdrawal induces increased firing in inferior colliculus neurons associated with audiogenic seizure susceptibility Exp. Neurol. 132 1 1995 91 98
9. M. Gasior, J.T. Ungard, and J.M. Witkin Preclinical evaluation of newly approved and potential antiepileptic drugs against cocaine-induced seizures J. Pharmacol. Exp. Ther. 290 3 1999 1148 1156
10. P. Granger, B. Biton, C. Faure, X. Vige, H. Depoortere, D. Graham, S.Z. Langer, B. Scatton, and P. Avenet Modulation of the gamma-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin Mol. Pharmacol. 47 6 1995 1189 1196
11. D.S. Gryder, and M.A. Rogawski Selective antagonism of GluR5 kainate-receptor-mediated synaptic currents by topiramate in rat basolateral amygdala neurons J. Neurosci. 23 18 2003 7069 7074
12. Q. Guo, and P. Kuang Studies of Qingyangshen (II): modulatory effect of co-treatment with qingyangshen and diphenylhydantoin sodium on rat hippocampal c-fos expression during seizures J. Tradit. Chin. Med. 16 1 1996 48 50
13. S.L. Hansen, B.B. Sperling, and C. Sanchez Anticonvulsant and antiepileptogenic effects of GABAA receptor ligands in pentylenetetrazole- kindled mice Prog. Neuropsychopharmacol. Biol. Psychiatry 28 1 2004 105 113
14. P.G. Kuang, S.Y. Lang, F.L. Dai, D.M. Zhang, F.Y. Zhang, C.Q. Pu, Y.M. Hu, and M.Q. Zhang Studies of qingyangshen (root of Cynanchum otophyllum). III. Effect of qingyangshen on acetylcholine concentration in mouse brain J. Tradit. Chin. Med. 5 4 1985 267 270
15. P.G. Kuang, S.Y. Lang, F.Y. Zhang, and Z.L. Yang Studies on qingyangshen (root of Cynanchum otophyllum). II. Effect of qingyangshen on metabolism of central monoamines J. Tradit. Chin. Med. 5 3 1985 191 194
16. P.G. Kuang, Y.X. Wu, F.J. Meng, P.Z. Kuang, D.S. Shao, and Q.Z. Mu Treatment of grand mal seizures with "Qingyangshen" (root of Cynanchum otophyllum) and observations on experimental animals J. Tradit. Chin. Med. 1 1 1981 19 24
17. J.B. Kuzmiski, W. Barr, G.W. Zamponi, and B.A. MacVicar Topiramate inhibits the initiation of plateau potentials in CA1 neurons by depressing R-type calcium channels Epilepsia 46 4 2005 481 489
18. R. Kuzniecky, S. Ho, J. Pan, R. Martin, F. Gilliam, E. Faught, and H. Hetherington Modulation of cerebral GABA by topiramate, lamotrigine, and gabapentin in healthy adults Neurology 58 3 2002 368 372
19. S. Lang, P. Kuang, J. Liu, K. Zhu, and X. Zhang The investigation of antiepileptic action of qingyangshen (QYS)-influences of QYS on the development of rat brain and memory behavior J. Tradit. Chin. Med. 10 3 1990 213 218
20. S. Lang, P. Kuang, P. Zuo, C. Yu, and X. Zhang The investigation of antiepiletic action of qingyangshen (QYS)-the modulatary action of QYS on the functions of GABAergic system in mice brain J. Tradit. Chin. Med. 11 3 1991 201 208
21. X. Li, and Y. Hu Gene expression profiling reveals the mechanism of action of anticonvulsant drug QYS Brain Res. Bull. 66 2 2005 99 105
22. K.J. Livak, and T.D. Schmittgen Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method Methods 25 4 2001 402 408
23. W. Loscher Development of tolerance to the anticonvulsant effect of GABAmimetic drugs in genetically epilepsy-prone gerbils Pharmacol. Biochem. Behav. 24 4 1986 1007 1013
24. W. Loscher Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action Prog. Neurobiol. 58 1 1999 31 59
25. W. Loscher, R. Jackel, and F. Muller Anticonvulsant and proconvulsant effects of inhibitors of GABA degradation in the amygdala-kindling model Eur. J. Pharmacol. 163 1 1989 1 14
26. R.L. Macdonald, M.J. Gallagher, H.J. Feng, and J. Kang GABA(A) receptor epilepsy mutations Biochem. Pharmacol. 68 8 2004 1497 1506
27. D. McCorry, D. Chadwick, and A. Marson Current drug treatment of epilepsy in adults Lancet Neurol. 3 12 2004 729 735
28. K. Morimoto, M. Fahnestock, and R.J. Racine Kindling and status epilepticus models of epilepsy: rewiring the brain Prog. Neurobiol. 73 1 2004 1 60
29. K. Morimoto, H. Sato, Y. Yamamoto, T. Watanabe, and H. Suwaki Antiepileptic effects of tiagabine, a selective GABA uptake inhibitor, in the rat kindling model of temporal lobe epilepsy Epilepsia 38 9 1997 966 974
30. Q.Z. Mu, J.R. Lu, and Q.L. Zhou Two new antiepilepsy compounds- otophyllosides A and B Sci. Sin. [B] 29 3 1986 295 301
31. A. Munoz, J.I. Arellano, and J. DeFelipe GABABR1 receptor protein expression in human mesial temporal cortex: changes in temporal lobe epilepsy J. Comp. Neurol. 449 2 2002 166 179
32. Y. Pei, J. Dai, W. Chen, Z. Lu, and Q. Mu Studies of the central pharmacological action of three kinds of general alkaloids obtained from plants of Cynanchum Linn J. Beijing Med. Univ. 19 2 1987 29 32
33. A. Pitkanen, I. Kharatishvili, S. Narkilahti, K. Lukasiuk, and J. Nissinen Administration of diazepam during status epilepticus reduces development and severity of epilepsy in rat Epilepsy Res. 63 1 2005 27 42
34. C.F. Poulsen, T.A. Simeone, T.E. Maar, V. Smith-Swintosky, H.S. White, and A. Schousboe Modulation by topiramate of AMPA and kainate mediated calcium influx in cultured cerebral cortical, hippocampal and cerebellar neurons Neurochem. Res. 29 1 2004 275 282
35. K.C. Ross, and J.R. Coleman Development genetic audiogenic seizure models: behavior and biological substrates Neurosci. Biobehav. Rev. 24 6 2000 639 653
36. U. Sayin, S. Cengiz, and T. Altug Vigabatrin as an anticonvulsant against pentylenetetrazol seizures Pharmacol. Res. 28 4 1993 325 331
37. S. Shinnar Tiagabine Semin. Pediatr. Neurol. 4 1 1997 24 33
38. G.J. Sills, E. Butler, G.G. Thompson, and M.J. Brodie Pharmacodynamic interaction studies with topiramate in the pentylenetetrazol and maximal electroshock seizure models Seizure 13 5 2004 287 295
39. G. Sperk, S. Furtinger, C. Schwarzer, and S. Pirker GABA and its receptors in epilepsy Adv. Exp. Med. Biol. 548 2004 92 103
40. S. Taverna, G. Sancini, M. Mantegazza, S. Franceschetti, and G. Avanzini Inhibition of transient and persistent Na+ current fractions by the new anticonvulsant topiramate J. Pharmacol. Exp. Ther. 288 3 1999 960 968
41. D.M. Treiman GABAergic mechanisms in epilepsy Epilepsia 42 Suppl. 3 2001 8 12
42. S. Uemura, and H. Kimura Amygdaloid kindling with bicuculline methiodide in rats Exp. Neurol. 102 3 1988 346 353
43. C.R. Valentine, J.L. Valentine, J. Seng, J. Leakey, and D. Casciano The use of transgenic cell lines for evaluating toxic metabolites of carbamazepine Cell Biol. Toxicol. 12 3 1996 155 165
44. R.H. Wallace, C. Marini, S. Petrou, L.A. Harkin, D.N. Bowser, R.G. Panchal, D.A. Williams, G.R. Sutherland, J.C. Mulley, I.E. Scheffer, and S.F. Berkovic Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures Nat. Genet. 28 1 2001 49 52
45. H.S. White, S.D. Brown, J.H. Woodhead, G.A. Skeen, and H.H. Wolf Topiramate modulates GABA-evoked currents in murine cortical neurons by a nonbenzodiazepine mechanism Epilepsia 41 Suppl. 1 2000 S17 S20
46. X. Zhang, A.A. Velumian, O.T. Jones, and P.L. Carlen Modulation of high-voltage-activated calcium channels in dentate granule cells by topiramate Epilepsia 41 Suppl. 1 2000 S52 S60